Other languages Rafael Holdings, Inc.

Equities

RFL

US75062E1064

Market Closed - Nyse Other stock markets 04:00:02 2024-07-05 pm EDT			5-day change	1st Jan Change
1.45 ^USD	+1.40%		+0.69%	-20.77%

Jun. 14	Rafael Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2024	CI
Jun. 11	Cyclo Therapeutics, Inc. announced that it has received $2 million in funding from Rafael Holdings, Inc.	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Rafael Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2024	Jun. 14
Rafael Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2024	Mar. 13
Rafael Holdings, Inc. Reports Earnings Results for the First Quarter Ended October 31, 2023	Dec. 14
Rafael Holdings, Inc. Reports Earnings Results for the Full Year Ended July 31, 2023	23-10-30
Rafael Holdings, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended July 31, 2023	23-10-30
Rafael Holdings, Inc. Announces Resignation of Rachel Jonas as Director	23-10-26
Rafael Holdings, Inc. Announces Resignation of Boris Pasche as Director	23-08-09
Rafael Holdings, Inc.'s Equity Buyback Plan Extended till July 1, 2024.	23-06-30
Rafael Holdings, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended April 30, 2023	23-06-13
Cyclo Therapeutics Signs $5 Million Funding Deal with Rafael Holdings	23-06-05
Rafael Holdings, Inc. announces an Equity Buyback for $5 million worth of its shares.	23-04-04
Rafael Holdings, Inc. authorizes a Buyback Plan.	23-04-03
Rafael Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023	23-03-14
Rafael Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended January 31, 2023	23-03-14
Rafael Holdings, Inc. Announces Resignation of David Polinsky as Chief of Staff	23-01-05
Rafael Holdings, Inc. Reports Earnings Results for the First Quarter Ended October 31, 2022	22-12-13
Rafael Holdings Explores Strategic Opportunities	22-11-14
Rafael Holdings, Inc. Reports Earnings Results for the Full Year Ended July 31, 2022	22-10-31
Rafael Holdings Closes on Sale of Headquarters Building; Shares Rise Pre-Bell	22-08-23
Rafael Holdings' Cornerstone Pharmaceuticals Completes Phase 1b Trial of Prospective Biliary Tract Cancer Therapy	22-08-03

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Rafael Holdings, Inc.

Equities

RFL

US75062E1064

Other languages

Filters